International Collaborations
Promoting collaboration with international stakeholders in the HIV and other infectious diseases fields is a central theme in EuroVacc’s mission, in order to broaden the discovery program and advance the product and clinical development of the most promising vaccine candidates.
SOLVE
SOLVE
Sustainable COVID-19 Vaccination for long-term vaccine immunity and effectiveness
CoVICIS
EU-Africa Concerted Action On SARS-CoV-2 Virus Variant and Immunological Surveillance (CoVICIS)
CARE
Corona Accelerated R&D in Europe
INCENTIVE
Indo-European Consortium for Next Generation Influenza Vaccine Innovation
PREPVACC
A combination efficacy study in Africa of two DNA-MVA- or DNA- Env protein HIV-1 vaccine regimens with pre-exposure prophylaxis
Completed projects
ASCENT
Acceleration of Novel Coronavirus Serological Test Development and Seroprevalence Study: An African-European Initiative
EHVA
European HIV Vaccine Alliance
